Quick Summary:
In a swiftly evolving healthcare landscape, staying informed is paramount to success. The companion diagnostics market is seeing remarkable growth, powered by the on-going rise of personalized medicine, an increase in industry collaborations, and substantial investments in life sciences. This comprehensive market research report offers holistic and up-to-date analysis, capturing the pulse of the current market scenario, latest trends, and main growth drivers.
Divided into market segments including end-users, indications, and geographical landscapes, this report highlights the mounting occurrence of illnesses such as breast cancer, the rise in product approvals for disease treatment and the expanding role of promotional activities as key factors driving market growth. With data sourced from industry key participants and a robust vendor analysis, this report is a vital tool for any forward-thinking executive wishing to improve their market position, apply strategic foresight, and leverage upcoming growth opportunities, with insights on the future trends and challenges that will shape the market.
Market Growth Has Experienced a Change of 25.29% YoY in 2020
Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising use of personalized medicine, increased industry collaborations, and growing investments in the life sciences sector.
The companion diagnostics market is segmented as below:
By End-user
- Life science
- Health centers
- Others
By Indication
- Oncology
- Neurology
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the companion diagnostics market covers the following areas:
- Companion diagnostics market sizing
- Companion diagnostics market forecast
- Companion diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global companion diagnostics market: Abbott Laboratories, Abnova Corp., Agilent Technologies Inc., Amoy Diagnostics Co. Ltd., ARUP Laboratories, Bayer AG, BioGenex Laboratories Inc., bioMerieux SA, F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Invivoscribe Inc., Liquid Biotech USA Inc., Myriad Genetics Inc., NG Biotech, QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising occurrence of breast cancer.'
According to the report, one of the major drivers for this market is the rising use of personalized medicine.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Abnova Corp.
- Agilent Technologies Inc.
- Amoy Diagnostics Co. Ltd.
- ARUP Laboratories
- Bayer AG
- BioGenex Laboratories Inc.
- bioMerieux SA
- F. Hoffmann La Roche Ltd.
- Guardant Health Inc.
- Illumina Inc.
- Invivoscribe Inc.
- Liquid Biotech USA Inc.
- Myriad Genetics Inc.
- NG Biotech
- QIAGEN NV
- Quest Diagnostics Inc.
- Siemens AG
- Sysmex Corp.
- Thermo Fisher Scientific Inc.